OAM
WST icon

OP Asset Management’s West Pharmaceutical WST Stock Holding History

OP Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.88M Buy
8,029
+570
+8% +$174K 0.03% 379
2026
Q1 		$1.87M Sell
7,459
-734
-9% -$183K 0.02% 472
2025
Q4 		$2.25M Buy
8,193
+15
+0.2% +$4.1K 0.03% 409
2025
Q3 		$2.15M Buy
8,178
+473
+6% +$115K 0.03% 428
2025
Q2 		$1.69M Hold
7,705
– – 0.02% 486
2025
Q1 		$1.72M Buy
+7,705
New +$2.12M 0.03% 474

Other funds holding WST

TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

OP Asset Management's WST Position: Q2 2026 in Review

OP Asset Management increased its West Pharmaceutical (WST) stake by 7.6% in Q2 2026, buying an estimated $174K and bringing the position to 8,029 shares worth $2.88M. The position accounts for 0.03% of the portfolio, ranked #379.

OP Asset Management first reported a position in WST in Q1 2025 and has held it in 6 quarters since. 342 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • OP Asset Management held 8,029 shares of West Pharmaceutical worth $2.88M as of Q2 2026.
  • OP Asset Management bought 570 West Pharmaceutical shares in Q2 2026, an estimated $174K.
  • West Pharmaceutical made up 0.03% of OP Asset Management's portfolio in Q2 2026, its #379 holding.
  • OP Asset Management first reported a position in West Pharmaceutical in Q1 2025 and has held it in 6 quarters since.
  • 342 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.